Niagen Bioscience (NAGE) Insider JR Buys 31,746 Shares

Jaksch Frank JR recently purchased 31,746 shares of NAGE on June 24, 2026. This insider transaction is part of a series of buys by company insiders, reflecting ongoing activity within the company's leadership.

Other Institutional Activity in NAGE

Several institutional investors have been active in trading NAGE shares. BlackRock, Inc. reduced its position by 204,090 shares, leaving it with 3,871,619 shares valued at about $17.07 million. Meanwhile, SteelPeak Wealth, LLC opened a new position with 3,373,000 shares, valued at approximately $14.87 million. Arrowstreet Capital, Limited Partnership increased its holdings by 761,685 shares, ending with 2,378,437 shares worth around $10.49 million. Vanguard Capital Management LLC also opened a new position with 2,149,277 shares, valued at about $9.48 million. Tieton Capital Management, LLC increased its stake by 384,062 shares to 2,029,155 shares, valued at $8.95 million.

Niagen Bioscience, Inc. Stock Up 14.4%

Shares of NAGE traded near $3.42 on Saturday. The stock has been active with various institutional investors adjusting their positions. Although specific financial metrics like market cap and P/E ratio are not available, the company's recent trading activity suggests a dynamic interest among both institutional and insider participants.

Insider Buying and Selling at Niagen Bioscience, Inc.

On June 24, 2026, several insiders, including Jaksch Frank JR, Ng Wang Yu Gary, Cohen Ann, Patrick Kristin, Rubin Steven, and Shahbazi Hamed, each bought 31,746 shares of NAGE. These transactions were not part of any pre-planned trading schedule, indicating a direct investment interest by the company's leadership.

Analysts Set New Price Targets

Analysts continue to show interest in NAGE. On May 11, 2026, HC Wainwright & Co. maintained its 'buy' rating with a price target of $11. Canaccord Genuity also maintained a 'buy' rating with a target of $10 on May 5, 2026. The analyst consensus remains positive, with a strong buy recommendation prevailing among those tracking the stock.

Bottom Line

The recent insider purchases by Jaksch Frank JR and other executives at NAGE highlight ongoing interest and confidence from within the company. Institutional investors have also been actively trading the stock, suggesting varied strategies among major players. While the current stock price and analyst ratings reflect optimism, these 13F filings and insider transactions provide a backward-looking snapshot of investor sentiment.